Reported about 5 hours ago
CoreWeave Inc. has decided not to increase its $9 billion bid for Core Scientific Inc., despite pushback from proxy advisers advising investors to reject the offer due to valuation concerns. CEO Michael Intrator expressed confidence in the pricing of the deal, which is seen as strategically sensible but may expose Core Scientific shareholders to market volatility. As CoreWeave expands its role in AI infrastructure, the deal’s future will be put to a vote, with some investors arguing for a higher valuation.
Source: YAHOO